Marken
Marken, a leading global provider of supply chain solutions for the pharmaceutical and life sciences industries, is headquartered in the United States. Founded in 1980, Marken has established itself as a trusted partner in clinical trial logistics, offering specialised services that include temperature-controlled transportation, clinical trial supply management, and home healthcare solutions. With a strong operational presence across North America, Europe, and Asia, Marken is renowned for its commitment to quality and compliance, ensuring the safe and efficient delivery of critical medical products. The company’s unique approach combines advanced technology with a deep understanding of regulatory requirements, positioning it as a market leader in the logistics sector. Notable achievements include its extensive network of depots and a robust track record in supporting complex clinical trials, making Marken an indispensable ally in the advancement of global healthcare.
DitchCarbon Score
How does Marken's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Marken's score of 42 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Marken's reported carbon emissions
In 2023, Marken reported total carbon emissions of approximately 73,357,000 kg CO2e. This figure includes 3,271,000 kg CO2e from Scope 1 emissions, 4,133,000 kg CO2e from Scope 2 emissions, and a significant 65,953,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 7,403,000 kg CO2e. Comparatively, in 2022, Marken's total emissions were about 70,805,000 kg CO2e, with Scope 1 at 2,842,000 kg CO2e, Scope 2 at 3,916,000 kg CO2e, and Scope 3 at 64,048,000 kg CO2e. This indicates a slight increase in total emissions year-on-year. Marken has committed to a long-term reduction pathway aligned with the Paris Agreement, aiming for net zero carbon emissions by 2050. This commitment encompasses all scopes of emissions, with specific targets for Scope 1 and Scope 2 emissions. The company is actively working towards these goals, demonstrating its dedication to sustainability within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,842,000 | 0,000,000 |
| Scope 2 | 3,916,000 | 0,000,000 |
| Scope 3 | 64,048,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Marken is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
